Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06604884 · ClinicalTrials.gov registry record
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
A clinical trial of Intracranial Aneurysm, sponsored by Medtronic Neurovascular Clinical Affairs.
- Recruiting
- Registry status
- 118
- Enrollment target
- 2
- Study locations
NCT06604884: Recruiting study of Intracranial Aneurysm, sponsored by Medtronic Neurovascular Clinical Affairs.
NCT06604884 is a study of Intracranial Aneurysm that is actively recruiting participants, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 118 participants, below the 9,188-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06604884, a study of Intracranial Aneurysm, is actively recruiting participants, sponsored by Medtronic Neurovascular Clinical Affairs.
- RECRUITING
- Registry status
- 118 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the Pipeline™ Vantage Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Vantage PAS") is to collect safety and effectiveness data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Vantage Embolization Device with Shield Technology™ ("Pipeline™ Vantage Device") in a post approval setting.
Primary Outcome
Incidence of complete occlusion of the target intracranial aneurysm (Raymond-Roy I) without significant parent artery stenosis (≤ 50%) nor re-treatment of the target intracranial aneurysm at 1-year post-procedure.
Conditions Studied
Interventions
- DEVICE Treatment of Intracranial Aneurysms
Study Locations (2)
Georgia
- Wellstar Research Institute - Marietta
Michigan
- McLaren Healthcare - Flint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2025-12-12 |
| Est. Completion | 2033-09 |
What NCT06604884 shows while recruiting
NCT06604884 is an observational study that tracks outcomes without assigning an intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 9,188-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Treatment of Intracranial Aneurysms is the first listed.
NCT06604884 reports a single indexed study location in Georgia, Michigan.
Frequently Asked Questions
What is clinical trial NCT06604884 about?
NCT06604884 is a clinical study titled "NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study". The purpose of the Pipeline™ Vantage Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Vantage PAS") is to collect safety and effectiveness data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Vantage Embolization Device with Shiel...
What is the current status of trial NCT06604884?
This trial is currently recruiting. The enrollment target is 118 participants. The study started on 2025-12-12. Estimated completion is 2033-09.
What conditions does trial NCT06604884 study?
This clinical trial studies the following conditions: Intracranial Aneurysm.
What interventions are being tested in trial NCT06604884?
The interventions under investigation include: Treatment of Intracranial Aneurysms (DEVICE).
Who is sponsoring clinical trial NCT06604884?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06604884 being conducted?
This trial has 2 study locations across Georgia, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06604884's enrollment target sits among peer trials
118 13th of 14 higher than 2 of 14 other Intracranial Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracranial Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Product Surveillance Registry
RECRUITING
-
Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry
RECRUITING
-
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
RECRUITING
-
@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms
RECRUITING
-
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
RECRUITING · NA
-
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI